Benzinga | Aug 9, 2021 04:23PM EDT

Ocular Therapeutix Q2 EPS $(0.25) Misses $(0.21) Estimate, Sales $11.72M Beat $11.60M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 60.94 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $11.72 million which beat the analyst consensus estimate of $11.60 million by 1.02 percent. This is a 646.85 percent increase over sales of $1.57 million the same period last year.